Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

VeriSign, Inc.

VRSN
Technology · Software - Infrastructure

VeriSign, Inc.'s balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup.

The sharpest disagreement: the engine is strong, but at the 81st percentile of its own range you are paying full price for it.

The price is topping out (5 weeks in) while the P/E sits at the 81st percentile of its own 4-year range. But the balance sheet is under water: net worth is negative, so shareholders sit behind everyone the company owes. What settles it: whether the business can earn its way back to positive equity before dilution or restructuring gets there first.

Stage
Mixed
partial read
Price
$299
+12.7% 1Y
P/E
32.5×
81st pctile
of its own 4-year range
Revenue (Mar 26)
$0.4 B
+7.5% YoY
Profit (Mar 26)
$0.2 B
+5.0% YoY
Operating margin
67.4%
−0.1 pp YoY
Cash conversion
116%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

VeriSign, Inc. trades at $299, losing momentum at the top and 5 weeks into that stage. That is +16.3% against its own 200-day average. It sits at 89% of a 52-week range of $216 to $310. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (1 week and counting).

Today the stock is losing momentum at the top — week 5 of stage 3. At $299 it trades +16.3% versus its 200-day average and sits at 89% of its 52-week range ($216–$310).

Aug 26: $299 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+16.3% versus the 200-day line, week 5 of stage 3
Price50-day avg200-day avg
S1S1S4S3S2S1$321$280$239$198$157$$299$257Jul 23Apr 24Jan 25Oct 25Aug 26
S1S1S4S3S2S1$321$280$239$198$157$$299$257Jul 23Jan 25Aug 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (527 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 16Aug 26

Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +250% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-07-31) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

VeriSign, Inc. trades at 32.5× P/E, at the pricey end of its own range (81st percentile). Its long-run median P/E is 28.6×, measured across 4.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 32.5× is at the pricey end of its own range (81st percentile), against a long-run median of 28.6× measured over 4.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 32.5× vs a 28.6× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 4.3-year window; loss-period spikes above 35× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
at the pricey end of its own range (81st percentile)
P/EMedianEPS (TTM) (quarterly)
35.9×$9.831.8×$7.327.7×$4.923.5×$2.419.4×$0.0×$33.06×$9Apr 22Apr 23May 24Jul 25Aug 26
35.9×$9.831.8×$7.327.7×$4.923.5×$2.419.4×$0.0×$33.06×$9Apr 22May 24Aug 26
PEG 1.74 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 20 quarters.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
1.8×1.6×1.4×1.2×0.9××1.74×Sep 21Sep 22Dec 23Mar 25Jun 26
1.8×1.6×1.4×1.2×0.9××1.74×Sep 21Dec 23Jun 26
P/E
32.5×
81st percentile of 4y
PEG
2.77
derived from 3-year earnings growth

Why the multiple sits where it does: over the past year annual EPS moved +10.1% against a +12.7% price move — the price outran earnings, pushing the multiple UP its own range.

The price move, decomposed: over 3y, of the +13.4%/yr price move, ~+10.2%/yr came from earnings growth and ~+3.2 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

VeriSign, Inc. reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but no return curve is held to confirm the Consistent bar. The read is built from 12 quarters across 3 curves, on partial evidence.

Growth, year by year: revenue +6.4% in FY25, profit +5.1% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
7.0%30%6.4%18%5.8%6.3%5.1%−5.6%4.5%−17%%%6.4%5.1%FY21FY23FY25
7.0%30%6.4%18%5.8%6.3%5.1%−5.6%4.5%−17%%%6.4%5.1%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising, profit accelerating
RevenueProfitEPS
7.2%30%6.4%19%5.5%7.3%4.7%−4.0%3.9%−15%%%7%6.3%10.6%Jun 23Sep 24Mar 26
7.2%30%6.4%19%5.5%7.3%4.7%−4.0%3.9%−15%%%7%6.3%10.6%Jun 23Sep 24Mar 26
Revenue growth
Steady high
latest +7.0% · span +4.1% to +7.0%
Profit growth
Rising
latest +6.3% · span −12.2% to +20.6%
EPS growth
Rising
latest +10.6% · span −7.8% to +26.7%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

The return-on-capital curve is not shown — net worth is negative, so a return on capital is not a meaningful number in any basis. This is a distressed balance sheet, and the stage is read from the growth curves alone.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+6.4%+5.3%
Profit+5.1%+7.4%
EPS+10.1%+12.2%
Stock price+12.7%+13.4%+6.9%+13.4%
Revenue YoY (Mar 26)
+7.5%
latest quarter vs a year ago
Profit YoY (Mar 26)
+5.0%
latest quarter vs a year ago
Revenue 10y
5.7%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

60.5/100 — rank 4 of 28 in Software - Infrastructure · 58% evidence confidence

VeriSign, Inc. scores 60.5 out of 100 against the 28 companies it is compared with in Software - Infrastructure, ranking 4. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 22.2 + 21.6 + 10.6 + 6.1 = 60.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

VeriSign, Inc. reported $0.4 B of revenue in the Mar 26 quarter, +7.5% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 5.7% a year. The last full year, FY25, came in at $1.7 B. The last four reported quarters add to $1.7 B.

FY25 revenue came in at $1.7 B (+6.4% on the year), capping 4 years at 5.7% compound. The latest quarter (Mar 26) printed $0.4 B, +7.5% year on year — the 12th consecutive quarter of year-over-year growth.

FY25 revenue $1.7 B (+6.4% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
5.7% a year over 4 years
RevenueYoY growth
1.87.0%1.36.4%0.95.8%0.45.1%0.04.5%$ B%$2B6.4%FY21FY23FY25
1.87.0%1.36.4%0.95.8%0.45.1%0.04.5%$ B%$2B6.4%FY21FY23FY25
Mar 26: $0.4 B (+7.5% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
12th straight quarter of growth
Revenue (quarterly)YoY growth
0.58.1%0.36.6%0.25.2%0.13.7%0.02.2%$ B%$0B7.5%Jun 23Sep 24Mar 26
0.58.1%0.36.6%0.25.2%0.13.7%0.02.2%$ B%$0B7.5%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +7.0% growth against the decade's 5.7% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +7.0% over the last 4 quarters against +5.8%/yr over the last 8 — stabilising; TTM profit +6.3% vs +0.6%/yr — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

VeriSign, Inc.'s operating margin is 67.4% in the Mar 26 quarter, −0.1 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 65.4% to 67.9%. The current quarter sits inside that band.

The latest quarter's operating margin is 67.4%, −0.1 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 65.4%–67.9%.

🚨 Why the margin moved: operating margin went −0.1 pp year on year while gross margin went +0.9 pp — the loss came mostly from the gross line: input costs and pricing.

FY25: 67.5% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
within a 65.4–67.9% band over 5 years
operating marginYoY change (pp)
68.1%1.0%67.4%0.6%66.7%0.3%65.9%−0.1%65.2%−0.5%%%67.5%−0.4%FY21FY23FY25
68.1%1.0%67.4%0.6%66.7%0.3%65.9%−0.1%65.2%−0.5%%%67.5%−0.4%FY21FY23FY25
Mar 26: 67.4% operating margin (−0.1 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
70%3.9%68%2.0%67%0.0%66%−2.0%65%−3.9%%%67.4%−0.1%Jun 23Sep 24Mar 26
70%3.9%68%2.0%67%0.0%66%−2.0%65%−3.9%%%67.4%−0.1%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

VeriSign, Inc. earned $0.2 B of net profit in the Mar 26 quarter, +5.0% year on year. It is the 5th consecutive quarter of growth. Full-year FY25 profit was $0.8 B. The 4-year compound rate is 1.6%. That is 48.8% of the quarter's revenue. The same quarter a year earlier earned $0.2 B.

Mar 26 profit was $0.2 B, +5.0% year on year — the 5th consecutive quarter of growth. On the full year, FY25 printed $0.8 B (+5.1%), and the 4-year compound rate is 1.6%.

FY25 profit $0.8 B (+5.1% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
1.6% a year over 4 years
Net profitYoY growth
0.925%0.715%0.44.1%0.2−6.4%0.0−17%$ B%$1B5.1%FY21FY23FY25
0.925%0.715%0.44.1%0.2−6.4%0.0−17%$ B%$1B5.1%FY21FY23FY25
Mar 26: $0.2 B (+5.0% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
5th straight quarter of growth
Net profit (quarterly)YoY growth
0.2850%0.2129%0.148.8%0.07−12%0.00−33%$ B%$0B5%Jun 23Sep 24Mar 26
0.2850%0.2129%0.148.8%0.07−12%0.00−33%$ B%$0B5%Jun 23Sep 24Mar 26

Why profit moved: revenue contributed +7.5% and the margin −0.1 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +6.4% vs revenue +7.0%. Profit and revenue are moving roughly in step.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 116% of VeriSign, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $1.1 B of operating cash against $0.8 B of profit. After $0.0 B of capital spending, $1.1 B was left as free cash.

FY25: operating cash of $1.1 B against reported profit of $0.8 B, leaving free cash of $1.1 B after $0.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 116% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $1.1 B vs profit $0.8 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
116% of 3-year profit arrived as cash
Operating cashNet profitFree cash
1.20.90.60.30.0$ B$1B$1B$1BFY21FY23FY25
1.20.90.60.30.0$ B$1B$1B$1BFY21FY23FY25
Jun 26: operating cash $0.2 B Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.33154%0.25133%0.17113%0.0892%0.0071%$ B%$0B129%Sep 23Dec 24Jun 26
0.33154%0.25133%0.17113%0.0892%0.0071%$ B%$0B129%Sep 23Dec 24Jun 26

Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

VeriSign, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY25: capex $0.0 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.050.040.030.010.00$ B$0BFY21FY23FY25
0.050.040.030.010.00$ B$0BFY21FY23FY25
Jun 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
0.0320.310.0240.270.0160.220.0080.180.0000.14$ B$ B$0B$0BSep 23Dec 24Jun 26
0.0320.310.0240.270.0160.220.0080.180.0000.14$ B$ B$0B$0BSep 23Dec 24Jun 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

VeriSign, Inc. earns a ROE of −39% in FY25. That is up from a trough of −62% in FY21. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 50.0% net margin on 1.25× asset turns.

FY25 ROE is −39%, recovered from a FY21 trough of −62% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY25): 50.0% net margin × 1.25× asset turns × −0.62× balance-sheet leverage ≈ −38.8% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.

FY25: ROE −39% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 7.6% cost of capital used on this page.
the climb back from FY21's −62%
ROEROIC (annual)WACC
408%282%156%29%−97%%−38.6%373.3%FY21FY23FY25
408%282%156%29%−97%%−38.6%373.3%FY21FY23FY25
Dec 25: ROIC 484.6% (TTM) vs WACC 7.6% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
1,242%894%547%199%−149%%484.6%−41.2%Sep 23Dec 24Jun 26
1,242%894%547%199%−149%%484.6%−41.2%Sep 23Dec 24Jun 26
11 · Dividend

Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.

VeriSign, Inc. paid $3.12 per share over the last four reported quarters. The most recent declaration was $0.81 for Mar 26. Against the current price of $299 that is a trailing yield of 1.04%, measured on dividends already paid rather than on a forecast.

VeriSign, Inc. paid $3.12 per share across the last four reported quarters, most recently $0.81 for Mar 26. Against the current price of $299 the trailing twelve months work out to 1.04% — trailing dividends measured against today's price, not a forward estimate.

Dividend per share by quarter Declared dividend per share, $ B, per reported quarter. 4 quarters on file.
latest $0.81 (Mar 26)
Dividend per share
0.90.70.40.20.0$ B$1BJun 25Sep 25Mar 26
0.90.70.40.20.0$ B$1BJun 25Sep 25Mar 26
12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

VeriSign, Inc.'s net worth is negative — it owes more than it owns — so a debt-to-equity ratio is not meaningful here. On the annual view that ratio went from −1.42 in FY21 to −0.83 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.

Jun 26: total debt of $2.3 B against shareholder equity of $−2.3 B — a debt-to-equity of −1.04. On the annual view, debt-to-equity went from −1.42 (FY21) to −0.83 (FY25). The returns on this page are earned, not borrowed.

FY25: debt $1.8 B at −0.83× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
1.9−0.8×1.4−1.0×1.0−1.1×0.5−1.3×0.0−1.5×$ B×$2B−0.83×FY21FY23FY25
1.9−0.8×1.4−1.0×1.0−1.1×0.5−1.3×0.0−1.5×$ B×$2B−0.83×FY21FY23FY25
Jun 26: debt $2.3 B, debt-to-equity −1.04 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
2.5−0.8×1.9−0.9×1.3−1.0×0.6−1.1×0.0−1.2×$ B×$2B−1.04×Sep 23Dec 24Jun 26
2.5−0.8×1.9−0.9×1.3−1.0×0.6−1.1×0.0−1.2×$ B×$2B−1.04×Sep 23Dec 24Jun 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

2.0% of VeriSign, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 2.2 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 2.0% of the float is sold short, and at typical trading volumes it would take about 2.2 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
2.0%
of the tradable float
Days to cover
2.2
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

VeriSign, Inc.: the Z-score reads −2.68. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

🚨 Why it matters: a Z-score of −2.68 is inside the distress zone — the balance sheet is a real risk, not a detail.

The safety line in one sentence: the Z-score reads −2.68.

15 · Related companies · Software - Infrastructure
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Fortinet, Inc.FTNT 67.2/100Thin evidence · provisional58% evidence LEADER 21.4/35 Revenue — · PAT — · OPM change 1.9 pp 45% evidence 17.8/25 ROCE 11.6% · OPM 31.4% 76% evidence 9.4/20 P/E 54.1× · PEG — 15% evidence 18.6/20 RS sector 39.5% · RS bench 54.1% · 1Y 126.2%12 of 12 weeks ahead 100% evidence
Exact sum: 21.4 + 17.8 + 9.4 + 18.6 = 67.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
2NetApp, Inc.NTAP 65.4/100Favorable setup85% evidence LEADER 19.4/35 Revenue 5.4% · PAT 7.6% · OPM change 7.2 pp 95% evidence 16.1/25 ROCE 8.3% · OPM 27.3% 76% evidence 11.9/20 P/E 17.1× · PEG 1.43 65% evidence 18.0/20 RS sector 27.3% · RS bench 40.7% · 1Y 79.3%12 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 16.1 + 11.9 + 18 = 65.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Corpay, Inc.CPAY 62.9/100Mixed-positive evidence81% evidence BREAKING OUT 21.9/35 Revenue 18.2% · PAT 16.1% · OPM change 7.9 pp 83% evidence 15.2/25 ROCE 5.8% · OPM 50.4% 76% evidence 14.3/20 P/E 17.4× · PEG 1.01 65% evidence 11.5/20 RS sector -0.1% · RS bench 11.2% · 1Y 31.4%5 of 12 weeks ahead 100% evidence
Exact sum: 21.9 + 15.2 + 14.3 + 11.5 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4VeriSign, Inc.this pageVRSN 60.5/100Thin evidence · provisional58% evidence BASING 22.2/35 Revenue — · PAT — · OPM change 1.1 pp 45% evidence 21.6/25 ROCE 1141.8% · OPM 68.5% 76% evidence 10.6/20 P/E 27.3× · PEG — 15% evidence 6.1/20 RS sector -7.4% · RS bench 2.9% · 1Y 10%4 of 12 weeks ahead 100% evidence
Exact sum: 22.2 + 21.6 + 10.6 + 6.1 = 60.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
5Palantir Technologies Inc.PLTR 60.0/100Mixed-positive evidence71% evidence TURNING 29.3/35 Revenue 67.7% · PAT 100% · OPM change 26.3 pp 83% evidence 15.9/25 ROCE 10.3% · OPM 46.2% 76% evidence 8.9/20 P/E 164.4× · PEG — 15% evidence 5.9/20 RS sector -15.6% · RS bench -6.3% · 1Y -13.1%1 of 12 weeks ahead 100% evidence
Exact sum: 29.3 + 15.9 + 8.9 + 5.9 = 60 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -15.6% and the one-year return is -13.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
6CrowdStrike Holdings, Inc.CRWD 55.7/100Mixed-positive evidence67% evidence LEADER 22.2/35 Revenue 23.2% · PAT — · OPM change 8.6 pp 71% evidence 6.5/25 ROCE -0.5% · OPM -2.2% 76% evidence 8.5/20 P/E 582.1× · PEG — 15% evidence 18.5/20 RS sector 32.3% · RS bench 46% · 1Y 99%12 of 12 weeks ahead 100% evidence
Exact sum: 22.2 + 6.5 + 8.5 + 18.5 = 55.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Okta, Inc.OKTA 54.4/100Mixed-positive evidence75% evidence BREAKING OUT 18.1/35 Revenue 11.8% · PAT 90% · OPM change 1.6 pp 95% evidence 8.2/25 ROCE 0.8% · OPM 7.3% 76% evidence 9.5/20 P/E 53.4× · PEG — 15% evidence 18.6/20 RS sector 27.6% · RS bench 40.8% · 1Y 61.6%12 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 8.2 + 9.5 + 18.6 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8F5, Inc.FFIV 53.7/100Thin evidence · provisional58% evidence LEADER 16.7/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence 14.2/25 ROCE 4.4% · OPM 22.1% 76% evidence 10.5/20 P/E 33.1× · PEG — 15% evidence 12.3/20 RS sector 6.8% · RS bench 18.3% · 1Y 28.1%12 of 12 weeks ahead 100% evidence
Exact sum: 16.7 + 14.2 + 10.5 + 12.3 = 53.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9Toast, Inc.TOST 53.2/100Mixed-positive evidence71% evidence TURNING 25.0/35 Revenue 23.4% · PAT 100% · OPM change 3.5 pp 83% evidence 10.7/25 ROCE 5.9% · OPM 6.7% 76% evidence 9.9/20 P/E 40.8× · PEG — 15% evidence 7.6/20 RS sector -15.1% · RS bench -6% · 1Y -21.5%2 of 12 weeks ahead 100% evidence
Exact sum: 25 + 10.7 + 9.9 + 7.6 = 53.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10GoDaddy Inc.GDDY 52.0/100Thin evidence · provisional58% evidence ASLEEP 21.2/35 Revenue — · PAT — · OPM change 3.8 pp 45% evidence 15.3/25 ROCE 6.8% · OPM 24.5% 76% evidence 11.4/20 P/E 12.6× · PEG — 15% evidence 4.1/20 RS sector -33% · RS bench -26% · 1Y -33.2%1 of 12 weeks ahead 100% evidence
Exact sum: 21.2 + 15.3 + 11.4 + 4.1 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11Microsoft CorporationMSFT 51.5/100Thin evidence · provisional58% evidence TURNING 16.7/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence 16.2/25 ROCE 7.6% · OPM 46.3% 76% evidence 10.8/20 P/E 20.8× · PEG — 15% evidence 7.8/20 RS sector -11.2% · RS bench -1.5% · 1Y -5.6%2 of 12 weeks ahead 100% evidence
Exact sum: 16.7 + 16.2 + 10.8 + 7.8 = 51.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12DigitalOcean Holdings, Inc.DOCN 51.2/100Mixed-positive evidence71% evidence FADING 16.8/35 Revenue 17.7% · PAT 100% · OPM change -3.7 pp 83% evidence 10.7/25 ROCE 2.2% · OPM 14.2% 76% evidence 10.4/20 P/E 37.5× · PEG — 15% evidence 13.3/20 RS sector 35.2% · RS bench 50.5% · 1Y 290%11 of 12 weeks ahead 100% evidence
Exact sum: 16.8 + 10.7 + 10.4 + 13.3 = 51.2 · Decision use: Price leads the evidence: RS versus the benchmark is 50.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
13Nutanix, Inc.NTNX 50.6/100Mixed-positive evidence75% evidence BREAKING OUT 19.0/35 Revenue -1.9% · PAT 100% · OPM change 5.2 pp 95% evidence 11.0/25 ROCE 3.7% · OPM 19.3% 76% evidence 9.8/20 P/E 43× · PEG — 15% evidence 10.8/20 RS sector -6.3% · RS bench 2.9% · 1Y -14.1%11 of 12 weeks ahead 100% evidence
Exact sum: 19 + 11 + 9.8 + 10.8 = 50.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Rubrik, Inc.RBRK 50.1/100Mixed-positive evidence64% evidence BREAKING OUT 25.7/35 Revenue 45.9% · PAT — · OPM change 19.8 pp 71% evidence 3.1/25 ROCE -5.3% · OPM -13.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 11.3/20 RS sector -5.3% · RS bench 4.2% · 1Y -7.3%12 of 12 weeks ahead 100% evidence
Exact sum: 25.7 + 3.1 + 10 + 11.3 = 50.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Samsara Inc.IOT 49.3/100Mixed-negative evidence67% evidence BREAKING OUT 24.5/35 Revenue 29.6% · PAT — · OPM change 10.6 pp 71% evidence 7.1/25 ROCE 0.5% · OPM 1.5% 76% evidence 8.6/20 P/E 304.9× · PEG — 15% evidence 9.1/20 RS sector -9.4% · RS bench 0.2% · 1Y 14.4%7 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 7.1 + 8.6 + 9.1 = 49.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Gen Digital Inc.GEN 48.8/100Mixed-negative evidence74% evidence BREAKING OUT 17.4/35 Revenue 27.1% · PAT 51.3% · OPM change -6.4 pp 62% evidence 15.8/25 ROCE 6.3% · OPM 62.6% 76% evidence 7.1/20 P/E 12× · PEG 2.71 65% evidence 8.5/20 RS sector -9.5% · RS bench 0.1% · 1Y -7.2%9 of 12 weeks ahead 100% evidence
Exact sum: 17.4 + 15.8 + 7.1 + 8.5 = 48.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Cloudflare, Inc.NET 48.8/100Mixed-negative evidence61% evidence BREAKING OUT 18.0/35 Revenue 31.6% · PAT — · OPM change 1.4 pp 62% evidence 3.5/25 ROCE -1.9% · OPM -9.7% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 17.3/20 RS sector 14.6% · RS bench 26.9% · 1Y 47.3%8 of 12 weeks ahead 100% evidence
Exact sum: 18 + 3.5 + 10 + 17.3 = 48.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Twilio Inc.TWLO 47.7/100Mixed-negative evidence64% evidence FADING 18.5/35 Revenue 15.6% · PAT — · OPM change 5.7 pp 62% evidence 8.5/25 ROCE 1.2% · OPM 7.7% 76% evidence 8.8/20 P/E 196.6× · PEG — 15% evidence 11.9/20 RS sector 10.6% · RS bench 22.8% · 1Y 96.7%10 of 12 weeks ahead 100% evidence
Exact sum: 18.5 + 8.5 + 8.8 + 11.9 = 47.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Akamai Technologies, Inc.AKAM 45.7/100Mixed-negative evidence81% evidence FADING 10.0/35 Revenue 6.1% · PAT -4% · OPM change -4.5 pp 83% evidence 11.6/25 ROCE 1.2% · OPM 10.7% 76% evidence 15.2/20 P/E 38.7× · PEG 0.7 65% evidence 8.9/20 RS sector -0.7% · RS bench 10.8% · 1Y 74.9%8 of 12 weeks ahead 100% evidence
Exact sum: 10 + 11.6 + 15.2 + 8.9 = 45.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
20MongoDB, Inc.MDB 44.8/100Mixed-negative evidence64% evidence BREAKING OUT 20.9/35 Revenue 23.7% · PAT — · OPM change 6.2 pp 71% evidence 5.0/25 ROCE -0.8% · OPM -3.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 8.9/20 RS sector -6.3% · RS bench 4.2% · 1Y 81.7%10 of 12 weeks ahead 100% evidence
Exact sum: 20.9 + 5 + 10 + 8.9 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Check Point Software Technologies Ltd.CHKP 43.3/100Thin evidence · provisional58% evidence TURNING 13.9/35 Revenue — · PAT — · OPM change -3 pp 45% evidence 14.2/25 ROCE 3.8% · OPM 27.7% 76% evidence 11.2/20 P/E 13.5× · PEG — 15% evidence 4.0/20 RS sector -39.5% · RS bench -32.8% · 1Y -32.4%1 of 12 weeks ahead 100% evidence
Exact sum: 13.9 + 14.2 + 11.2 + 4 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
22Oracle CorporationORCL 42.2/100Mixed-negative evidence85% evidence ASLEEP 16.1/35 Revenue 17.4% · PAT 37.3% · OPM change -0.1 pp 95% evidence 13.1/25 ROCE 3.4% · OPM 32% 76% evidence 12.4/20 P/E 38.7× · PEG 1.13 65% evidence 0.6/20 RS sector -39.7% · RS bench -33.5% · 1Y -41.7%5 of 12 weeks ahead 100% evidence
Exact sum: 16.1 + 13.1 + 12.4 + 0.6 = 42.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Palo Alto Networks, Inc.PANW 40.1/100Mixed-negative evidence85% evidence LEADER 7.9/35 Revenue 19.5% · PAT -31.9% · OPM change -15.7 pp 95% evidence 6.8/25 ROCE -0.7% · OPM -6.1% 76% evidence 5.5/20 P/E 147× · PEG 2.62 65% evidence 19.9/20 RS sector 40.1% · RS bench 54.3% · 1Y 119.3%12 of 12 weeks ahead 100% evidence
Exact sum: 7.9 + 6.8 + 5.5 + 19.9 = 40.1 · Decision use: Price leads the evidence: RS versus the benchmark is 54.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
24Zscaler, Inc.ZS 35.8/100Mixed-negative evidence64% evidence FADING 16.4/35 Revenue 24.6% · PAT — · OPM change 0.2 pp 71% evidence 4.5/25 ROCE -0.9% · OPM -3.5% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 4.9/20 RS sector -35.7% · RS bench -29.3% · 1Y -39.5%3 of 12 weeks ahead 100% evidence
Exact sum: 16.4 + 4.5 + 10 + 4.9 = 35.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25CoreWeave, Inc.CRWV 33.9/100Adverse evidence61% evidence ASLEEP 16.0/35 Revenue 100% · PAT — · OPM change -4.2 pp 62% evidence 5.4/25 ROCE -0.5% · OPM -6.9% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 2.5/20 RS sector -23.5% · RS bench -15.1% · 1Y -29.1%6 of 12 weeks ahead 100% evidence
Exact sum: 16 + 5.4 + 10 + 2.5 = 33.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Block, Inc.XYZ 31.0/100Adverse evidence71% evidence BREAKING OUT 5.2/35 Revenue 2.3% · PAT -68.8% · OPM change -8.5 pp 83% evidence 6.5/25 ROCE -0.6% · OPM -2.8% 76% evidence 9.6/20 P/E 47× · PEG — 15% evidence 9.7/20 RS sector -1.2% · RS bench 9.4% · 1Y 15.3%9 of 12 weeks ahead 100% evidence
Exact sum: 5.2 + 6.5 + 9.6 + 9.7 = 31 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Synopsys, Inc.SNPS 30.4/100Adverse evidence85% evidence ASLEEP 10.3/35 Revenue 39.5% · PAT -41.8% · OPM change -18.2 pp 95% evidence 9.8/25 ROCE 0.4% · OPM 5.3% 76% evidence 8.4/20 P/E 111.7× · PEG 1.75 65% evidence 1.9/20 RS sector -29.2% · RS bench -21.4% · 1Y -34.8%1 of 12 weeks ahead 100% evidence
Exact sum: 10.3 + 9.8 + 8.4 + 1.9 = 30.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Cerebras Systems Inc.CBRS 49.8/100Thin evidence · provisional41% evidence 25.6/35 Revenue 86.1% · PAT — · OPM change 20.8 pp 62% evidence 4.2/25 ROCE -0.9% · OPM -7.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 25.6 + 4.2 + 10 + 10 = 49.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is VeriSign, Inc.'s stock price today?

VeriSign, Inc. trades at $299, +12.7% over the past year. The company is valued at $27.0 B. The stock sits at 89% of its 52-week range of $216–$310, +16.3% versus its 200-day average. On the tape, the price is topping out, 5 weeks in. — as of 5 August 2026.

What were VeriSign, Inc.'s latest quarterly results?

VeriSign, Inc. reported revenue of $0.4 B and net profit of $0.2 B for the Mar 26 quarter. Revenue rose 7.5% and profit rose 5.0% year on year. Earnings per share were $2.34. The operating margin was 67.4%, 0.1 pp lower than a year earlier. — as of 5 August 2026.

What is VeriSign, Inc.'s revenue?

VeriSign, Inc. reported revenue of $0.4 B in the Mar 26 quarter, +7.5% year on year. For the full FY25 fiscal year, revenue was $1.7 B (+6.4%). Over the last 4 years revenue compounded at 5.7% a year. — as of 5 August 2026.

What is VeriSign, Inc.'s profit?

VeriSign, Inc. earned $0.2 B of net profit in the Mar 26 quarter, +5.0% year on year — the 5th straight quarter of growth. Full-year FY25 profit was $0.8 B. The operating margin ran 67.4% in the latest quarter. — as of 5 August 2026.

What is VeriSign, Inc.'s market cap?

VeriSign, Inc.'s market capitalisation is $27.0 B at a stock price of $299. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

What is VeriSign, Inc.'s P/E ratio?

VeriSign, Inc. trades at a P/E of 32.5×, at the 81st percentile of its own 4-year range, against a long-run median of 28.6×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.

Does VeriSign, Inc. pay a dividend?

Yes — VeriSign, Inc. declared $0.81 per share for Mar 26, and $3.12 per share across the last four reported quarters. — as of 5 August 2026.

What is VeriSign, Inc.'s dividend per share?

VeriSign, Inc.'s most recently declared dividend is $0.81 per share for Mar 26, giving $3.12 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.

What is VeriSign, Inc.'s dividend yield?

VeriSign, Inc.'s trailing dividend yield is 1.04%: $3.12 declared per share across the last four reported quarters, against a share price of $299. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.

Is VeriSign, Inc. overvalued?

On its own history, VeriSign, Inc. looks expensive against its own history: its P/E of 32.5× sits at the 81st percentile of its 4-year range (long-run median 28.6×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.

Is VeriSign, Inc. growing?

Yes — VeriSign, Inc. is growing: latest-quarter revenue +7.5% year on year, profit +5.0%, and the margin −0.1 pp at 67.4%. The 4-year compound rates are 5.7% (revenue) and 1.6% (profit). The earnings engine currently reads: improving — as of 5 August 2026.

How is VeriSign, Inc. performing?

VeriSign, Inc. is topping out, 5 weeks in. Its latest quarter's revenue rose 7.5% and profit rose 5.0% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 5 August 2026.

What stage is VeriSign, Inc. in?

Mixed — the growth curves are steadily positive, but no return curve is held to confirm the Consistent bar. The read comes from the last 12 quarters of growth (revenue growth +7.0% latest, profit growth +6.3% latest, eps growth +10.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.

Is VeriSign, Inc. in an uptrend?

It is stalling — the price is topping out (week 5 of stage 3), trading +16.3% versus its 200-day average and at 89% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.

Is VeriSign, Inc. beating the market?

Not lately — on a trailing-13-week view VeriSign, Inc. is currently behind the S&P 500 (1 week and counting; last ahead the week of 2026-07-31), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +250% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.

Will VeriSign, Inc.'s stock price go up?

This page publishes no price forecast for VeriSign, Inc. What it measures instead: the stock price is $299, the price is topping out 5 weeks in. Its P/E of 32.5× sits at the 81st percentile of its own 4-year range. Direction is not something this site claims to know. — as of 5 August 2026.

Is the market betting against VeriSign, Inc.?

Somewhat — short interest is 2.0% of VeriSign, Inc.'s tradable float, about 2.2 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.

What is VeriSign, Inc.'s capex?

VeriSign, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 5 August 2026.

What is VeriSign, Inc.'s cash flow?

VeriSign, Inc. generated $1.1 B of operating cash flow in FY25 and $1.1 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.8 B, so operating cash ran ahead of profit. — as of 5 August 2026.

Is VeriSign, Inc.'s profit real cash?

Yes — over the last 3 fiscal years, 116% of VeriSign, Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $1.1 B against reported profit of $0.8 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.

How financially safe is VeriSign, Inc.?

On the balance sheet, the Z-score reads −2.68 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.

Where is VeriSign, Inc. in its business cycle?

VeriSign, Inc.'s FY25 operating margin was 67.5%, against a 5-year band of 65.4%–67.9%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 67.4%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the VeriSign, Inc. story?

The sharpest disagreement: the engine is strong, but at the 81st percentile of its own range you are paying full price for it. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is VeriSign, Inc. a stock worth studying right now?

This is not investment advice. The machine read: VeriSign, Inc.'s balance sheet is under water — net worth is negative, so it owes more than it owns. This is a distressed, high-risk situation — the equity can be wiped by dilution or restructuring before operations recover. Not a value setup. The sharpest open question: whether the business can earn its way back to positive equity before dilution or restructuring gets there first. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI